Home › Funds › Westshore Wealth, LLC › AMRX
Westshore Wealth, LLC position in AMRX
AMNEAL PHARMACEUTICALS INC · Health Care
Westshore Wealth, LLC reported holding 1,366,274 shares of AMRX (AMNEAL PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$23.7M, representing 7.34% of its reported portfolio and ranking #3 among its reported holdings. Westshore Wealth, LLC has disclosed AMRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Westshore Wealth, LLC's AMRX position evolved
Westshore Wealth, LLC first disclosed a stake in AMRX in Q3 2025 at 1,381,910 shares (US$13.8M). The position peaked in Q2 2026 at 1,366,274 shares, worth US$23.7M. Across 4 filings, Westshore Wealth, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,366,274 shares valued at US$23.7M — a reduction of -7,710 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 1.38M | $13.83M | New |
| Q4 2025 | 1.38M | $17.41M | Hold |
| Q1 2026 | 1.37M | $17.08M | Reduce |
| Q2 2026 | 1.37M | $23.65M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AMRX and 13F data
AMRX (AMNEAL PHARMACEUTICALS INC) is a Health Care company. 47 other funds we track also report a position in AMRX — the largest reported positions include TPG GP A, LLC (US$213.4M), Rubric Capital Management LP (US$176.0M), Nantahala Capital Management, LLC (US$39.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AMRX
- TPG GP A, LLC 12.33M sh · $213.41M · Q2 2026
- Rubric Capital Management LP 10.17M sh · $176.02M · Q2 2026
- Nantahala Capital Management, LLC 2.27M sh · $39.27M · Q2 2026
- BlackBarn Capital Partners LP 1.30M sh · $22.50M · Q2 2026
- Penn Capital Management Company, LLC 1.18M sh · $20.48M · Q2 2026
- TUCKER ASSET MANAGEMENT LLC 1.01M sh · $17.50M · Q2 2026
- Phocas Financial Corp. 819.48K sh · $14.19M · Q2 2026
More on Westshore Wealth, LLC
FAQ
How long has Westshore Wealth, LLC held AMRX?
Westshore Wealth, LLC has disclosed AMRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Westshore Wealth, LLC's current position in AMRX?
As of Q2 2026, Westshore Wealth, LLC holds 1.37M shares of AMRX (AMNEAL PHARMACEUTICALS INC), valued at $23.65M, representing 7.34% of its reported portfolio and ranking #3.
Has Westshore Wealth, LLC been buying or selling AMRX?
In the latest 13F filing (Q2 2026), Westshore Wealth, LLC reduced its position in AMRX. The position peaked in Q2 2026 at 1.37M shares.
Which other funds hold AMRX?
Other major institutional holders of AMRX include TPG GP A, LLC, Rubric Capital Management LP, Nantahala Capital Management, LLC, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.